|
VKORC1L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.254800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.159000E-01 |
| Normal-vs-Stage2 |
6.560000E-01 |
| Normal-vs-Stage3 |
7.131600E-01 |
| Normal-vs-Stage4 |
9.322000E-01 |
| Stage1-vs-Stage2 |
7.976800E-01 |
| Stage1-vs-Stage3 |
1.339790E-01 |
| Stage1-vs-Stage4 |
3.858200E-01 |
| Stage2-vs-Stage3 |
4.194200E-01 |
| Stage2-vs-Stage4 |
6.298200E-01 |
| Stage3-vs-Stage4 |
8.019000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.327600E-01 |
| Normal-vs-AfricanAmerican |
2.156800E-01 |
| Normal-vs-Asian |
8.668800E-01 |
| Caucasian-vs-AfricanAmerican |
2.963800E-01 |
| Caucasian-vs-Asian |
4.324000E-01 |
| AfricanAmerican-vs-Asian |
1.690410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.547200E-01 |
| Normal-vs-Female |
3.894000E-01 |
| Male-vs-Female |
2.642400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.723600E-02 |
| Normal-vs-Age(41-60Yrs) |
8.489800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.404200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.363600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.077900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.765700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.196000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.156400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.628200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.682000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.575700E-02 |
| Classical-VS-Follicular |
1.578570E-04 |
| Classical-VS-Other |
2.631200E-01 |
| Classical-VS-Normal |
6.507800E-02 |
| Tall-VS-Follicular |
3.772400E-01 |
| Tall-VS-Other |
6.981200E-01 |
| Tall-VS-Normal |
7.287400E-01 |
| Follicular-VS-Other |
8.861600E-01 |
| Follicular-VS-Normal |
1.529790E-01 |
| Other-VS-Normal |
5.617200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.517200E-01 |
| Normal-vs-N1 |
9.125000E-01 |
| N0-vs-N1 |
9.796400E-01 |
|
|
